The Norwegian Antibiotics for Pneumonia in Children Study (NAPiC)
Sponsor: Alesund Hospital
Listed as NCT03446534, this PHASE4 trial focuses on Lower Respiratory Tract Infection and Pneumonia Childhood and remains ongoing. Sponsored by Alesund Hospital, it has been updated 7 times since 2018, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Recruiting PHASE4
▶ Show 2 earlier versions
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Mar 2018 — May 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Alesund Hospital
- Haukeland University Hospital
- Helse Stavanger HF
- Klinbeforsk
- Nordlandssykehuset HF
- Norwegian Institute of Public Health
- Oslo University Hospital
- Ostfold Hospital Trust
- St. Olavs Hospital
- University Hospital of North Norway
- University Hospital, Akershus
For direct contact, visit the study record on ClinicalTrials.gov .